The National Institutes of Health has awarded $20 million to the University of Kentucky to move research discoveries to healthcare solutions more quickly.
The five-year funding is the largest research funding award ever received by UK and will be used to support research at UK’s Center for Clinical and Translational Science, making it part of a select national biomedical research consortium.
The funding will also support infrastructure such as the Clinical Research Development and Operations Center at UK Albert B. Chandler Hospital, where patients participate in clinical research studies; educational programs for future investigators; research pilot grants and an informatics program.
“Receiving this award not only provides significant funding but also the recognition of being among the top biomedical research universities in the country,” said UK Provost Kumble Subbaswamy. “This award is the end result of much hard work and diligence by many, many people at the university who have demonstrated their expertise in clinical research and their ability to build successful interdisciplinary collaborations.”
“By receiving CTSA funding we will be able to accomplish goals that truly impact the health outcomes of people in Kentucky and beyond,” said Dr. Michael Karpf, executive vice president for health affairs at UK. “Having a top biomedical research program is imperative in our plan to become a major regional academic medical center and today’s announcement is an acknowledgement we are continuing to do what we need to do to meet that goal.”